The global cell and gene therapy manufacturing market will surpass $834.1B by 2035, driven by demand, bioprocessing advances, and regulatory growth.
Cell and Gene Therapy Manufacturing Market is led by Cell Therapy Manufacturing holding a 60.19% share in 2023, including stem and non-stem cell therapies.